Pharmacogenomics Market Worth $19.5 billion by 2031 -- Exclusive Report by Meticulous Research® [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Offering (Instrument, Consumables, Software), Technology (PCR, Sequencing, Microarray), Application (Oncology, Mental Health, Cardiology, Neurology, Infectious Disease), End User (Hospitals, Academic)–Global Forecast to 2031' published by Meticulous Research ® , the pharmacogenomics market is projected to reach $19.5 billion by 2031, at a CAGR of 8.9% during the forecast period 2024–2031. Download Sample Report- https://www.meticulousresearch.com/download-sample-report/cp_id=5366 Pharmacogenomics plays a pivotal role in the identification of response and non-response from an individual toward a particular drug. This helps in avoiding adverse events and optimizing drug dose. Drugs labeled with pharmacogenomic biomarkers provide information on drug exposure and clinical response variability, risk for adverse events, genotype-specific dosing, mechanisms of drug action, polymorphic drug target and disposition genes, and trial design features. Pharmacogenomic biomarkers are highly focu
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Global Vascular Closure Devices Market Set to Reach US$ 2.4 Billion by 2032, According to New 2024 Report [Yahoo! Finance]Yahoo! Finance
- United States Toxicology Laboratories Industry Research Report 2024 Featuring Abbott Laboratories, Laboratory Corporation Of America, Quest Diagnostics, and Clinical Reference Laboratory [Yahoo! Finance]Yahoo! Finance
- In-Vitro Diagnostic (IVD) Quality Control Market Research Report 2024-2028: Control Materials, QC Procedures, Instrument Calibration, Documentation and Record Keeping, Troubleshootin [Yahoo! Finance]Yahoo! Finance
- Global Companion Diagnostics Industry Research 2024: Epigenomics-Based Companion Diagnostics, Advancing Biomedical Imaging Fueling Growth - Forecast to 2033 [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 5/14/24 - Form 4
- 5/10/24 - Form 144
- 5/8/24 - Form 4
- ABT's page on the SEC website